| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |